Scienture Holdings (SCNX)
NASDAQ:SCNX
Want to see SCNX full AI Analyst Report?
SCNX Stock Chart & Stats
$0.55
-$0.13(-2.47%)
At close: 4:00 PM EST
$0.55
-$0.13(-2.47%)
Day’s Range― - ―
52-Week Range$0.24 - $2.60
Previous CloseN/A
Volume1.53K
Average Volume (3M)4.08M
Market Cap
$16.78M
Enterprise Value-$3.53B
Total Cash (Recent Filing)$3.54B
Total Debt (Recent Filing)$10.00M
Price to Earnings (P/E)―
Beta3.37
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,630,814
10 Day Avg. Volume11,411,402
30 Day Avg. Volume4,082,790
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)181.35
P/FCF Ratio>-0.01
Enterprise Value/Market Cap-210.15
Enterprise Value/Revenue-7.38K
Enterprise Value/Gross Profit42.31K
Enterprise Value/Ebitda89.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance Sheet HealthVery low reported leverage reduces near-term refinancing and solvency risk, giving management more time to execute commercialization. A light debt load preserves optionality for R&D and partnering and lowers immediate liquidity pressure versus highly levered peers.
Durable IP Protection For ArbliA U.S. patent extending exclusivity to 2041 materially strengthens product defensibility for the ready-to-use losartan oral liquid. Long-dated IP supports sustainable pricing, deters generic entrants, and improves bargaining power for commercialization partners and payors.
High Gross Margin And TTM Revenue JumpA marked TTM revenue increase combined with high gross margins indicates favorable unit economics at the product level. If management controls SG&A and scales sales, these margins provide a structural path to profitability as commercialization progresses.
Bears Say
Ongoing Cash BurnSustained negative operating and free cash flows show the business consumes cash to operate and commercialize. This creates structural dependency on external financing, risks dilution or onerous funding terms, and constrains the firm's ability to invest without new capital.
Deeply Negative ProfitabilityHeavily negative margins indicate operating costs and below-the-line items greatly exceed revenue today. Without durable revenue growth or major cost rebalancing, losses will persist, undermining sustainable earnings generation and investor returns over the medium term.
Restrictive Financing CovenantsThe structured financing provides liquidity but creates structural constraints: broad security interests, triggers that can accelerate debt or raise rates, and limits on capital structure and exchange activity. These covenants reduce strategic flexibility and raise refinancing risk.
Scienture Holdings News
SCNX FAQ
What was Scienture Holdings’s price range in the past 12 months?
Scienture Holdings lowest stock price was $0.24 and its highest was $2.60 in the past 12 months.
What is Scienture Holdings’s market cap?
Scienture Holdings’s market cap is $16.78M.
When is Scienture Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scienture Holdings’s earnings last quarter?
Currently, no data Available
Is Scienture Holdings overvalued?
According to Wall Street analysts Scienture Holdings’s price is currently Overvalued.
Does Scienture Holdings pay dividends?
Scienture Holdings pays a Notavailable dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Scienture Holdings dividends here
What is Scienture Holdings’s EPS estimate?
Scienture Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scienture Holdings have?
Scienture Holdings has 40,630,814 shares outstanding.
What happened to Scienture Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scienture Holdings?
Currently, no hedge funds are holding shares in SCNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scienture Holdings
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Technical Analysis
Ownership Overview
16.82% Insiders
1.70% Mutual Funds
<0.01% Other Institutional Investors
80.47% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---